Recruiting
Phase 2

Transplantation Outcomes

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT06055608

Conditions

Kidney Transplant

Eligibility Criteria

Sex: All

Age: 13 - 20

Healthy Volunteers: Not accepted

Interventions

Sirolimus

Belatacept

Mycophenolate Mofetil

Tacrolimus (Group1)

Anti-Thymocyte Globulin (ATG)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-10. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2025-06-26.